Thermo Fisher Scientific Inc. (TMO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 1.19B | 3.46B | 2.24B | 1.4B | 723M | 3.29B | 2.17B | 1.96B | 1.25B | 3.72B | 2.41B | 1.54B |
| Operating CF Margin % | 10.83% | 28.3% | 20.13% | 12.89% | 6.98% | 28.87% | 20.44% | 18.59% | 12.09% | 34.2% | 22.83% | 14.41% |
| Operating CF Growth % | 64.87% | 5.08% | 3.37% | -28.62% | -42.21% | -11.63% | -10.27% | 27.27% | 71.6% | 6.77% | 24.63% | 0.79% |
| Net Income | 1.66B | 1.97B | 1.62B | 1.61B | 1.51B | 1.82B | 1.64B | 1.55B | 1.33B | 1.63B | 1.72B | 1.36B |
| Depreciation & Amortization | 736M | 727M | 662M | 685M | 706M | 740M | 740M | 790M | 836M | 839M | 853M | 855M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 68M | 84M | 70M | 61M | 67M | 74M |
| Deferred Taxes | -258M | 89M | -127M | -322M | -279M | 0 | -400M | -354M | -253M | -669M | -303M | -182M |
| Other Non-Cash Items | 170M | 224M | -2.07B | 147M | 206M | 132M | 89M | 108M | 58M | 139M | 91M | 149M |
| Working Capital Changes | -1.11B | 447M | 2.15B | -726M | -1.43B | 594M | 30M | -216M | -787M | 1.72B | -9M | -718M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | -333M | 0 | 0 | 0 | 209M | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | -27M | 0 | 0 | 0 | 598M | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 212M | 0 | 0 | 0 | -500M | 0 | 0 |
| Cash from Investing | -8.96B | 891M | -4.12B | -288M | -527M | 20M | -3.58B | -253M | -2.03B | -376M | -1.18B | -443M |
| Capital Expenditures | -376M | -465M | -404M | -294M | -362M | -480M | -272M | -301M | -347M | -405M | -332M | -284M |
| CapEx % of Revenue | 3.42% | 3.81% | 3.63% | 2.71% | 3.49% | 4.21% | 2.57% | 2.86% | 3.35% | 3.72% | 3.14% | 2.66% |
| Acquisitions | -8.87B | 0 | -4.04B | 0 | 0 | 0 | -3.11B | 16M | 4M | 11M | -909M | -47M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 51M | 77M | 104M | 53M | 99M | 500M | 1M | 5M | 7M | 18M | 60M | -112M |
| Cash from Financing | 1.09B | 3.53B | -632M | -991M | -102M | -3.67B | -1.19B | -114M | -1.82B | -1.43B | 1.85B | -1.46B |
| Debt Issued (Net) | 4.21B | 785M | -2B | -787M | 2B | -2.5B | -1.11B | -1M | 1.21B | -1.31B | 1.97B | -1.32B |
| Equity Issued (Net) | -3B | -3B | 2B | 0 | -2B | -1B | 0 | 0 | -3B | 0 | 0 | 0 |
| Dividends Paid | -162M | -162M | -163M | -162M | -149M | -149M | -150M | -149M | -135M | -136M | -135M | -135M |
| Share Repurchases | -3B | -3B | 2B | 0 | -2B | -1B | 0 | 0 | -3B | 0 | 0 | 0 |
| Other Financing | 40M | 5.9B | -469M | -42M | 45M | -17M | 67M | 36M | 109M | 14M | 18M | 4M |
| Net Change in Cash | -6.6B | 7.87B | -2.59B | 431M | 131M | -630M | -2.43B | 1.58B | -2.58B | 1.93B | 3.02B | -347M |
| Free Cash Flow | 816M | 2.99B | 1.83B | 1.1B | 361M | 2.81B | 1.89B | 1.66B | 904M | 3.32B | 2.08B | 1.26B |
| FCF Margin % | 7.41% | 24.49% | 16.5% | 10.18% | 3.48% | 24.66% | 17.87% | 15.74% | 8.74% | 30.48% | 19.69% | 11.75% |
| FCF Growth % | 126.04% | 6.48% | -3.12% | -33.39% | -60.07% | -15.31% | -9.03% | 32.09% | 233.58% | 12.97% | 49.78% | 22.9% |
| FCF per Share | 2.19 | 7.94 | 4.85 | 2.92 | 0.95 | 7.34 | 4.93 | 4.33 | 2.35 | 8.55 | 5.37 | 3.24 |
| FCF Conversion (FCF/Net Income) | 0.72x | 1.75x | 1.39x | 0.87x | 0.48x | 1.80x | 1.33x | 1.27x | 0.94x | 2.28x | 1.41x | 1.13x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |